Product Information
INVOKAMET XR 150-1,000 MG TAB is a brand product labeled by Janssen Pharmaceuticals Inc., priced at $9.5294 per EA under NDC 50458094301. Its NADAC has been published 492 times since Mar 22, 2017.
FDA first approved this application on Sep 20, 2016.
Strength
150; 1000 mg/1; mg/1
Manufacturer
Janssen Pharmaceuticals Inc.NDC
50458094301
Classification
Brand
Dosage Form
TABLET, FILM COATED, EXTENDED RELEASE
Route
ORAL
Effective Date
8/19/2026
Active Ingredients
CANAGLIFLOZIN; METFORMIN HYDROCHLORIDEApproval Type
New Drug (NDA)
FDA Application
NDA205879FDA Approved
9/20/2016
On Market Since
9/20/2016
Pharmacological Classes
Price Statistics
The NADAC for INVOKAMET XR 150-1,000 MG TAB has been published 492 times since Mar 22, 2017, and over the history we have for it it has risen 39.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $9.5294 per EA |
|---|---|
| All-time high | $9.5802 (Jan 15, 2025) |
| All-time low | $6.8210 (Apr 19, 2017) |
| 52-week high | $9.5521 |
| 52-week low | $9.5120 |
| Median price | $8.7421 |
| Average price | $8.6400 |
| Largest weekly change | +8.9% (Jan 10, 2018) |
| Weeks tracked | 492 |
| Tracking since | Mar 22, 2017 |
Generic Alternatives
The matcher finds 1 manufacturer offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). None of the shown alternatives sit below the current price. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Frequently asked questions
What is the NADAC price of INVOKAMET XR 150-1,000 MG TAB?
The current National Average Drug Acquisition Cost (NADAC) for INVOKAMET XR 150-1,000 MG TAB, manufactured by Janssen Pharmaceuticals Inc., is $9.5294 per EA (NDC 50458094301), effective Aug 19, 2026.
How has the price of INVOKAMET XR 150-1,000 MG TAB changed over time?
Over the history we have for it, the NADAC for INVOKAMET XR 150-1,000 MG TAB has risen 39.7%. It has been tracked across 492 weekly CMS publications since Mar 22, 2017.
What are the highest and lowest recorded NADAC prices for INVOKAMET XR 150-1,000 MG TAB?
Since Mar 22, 2017, the NADAC for INVOKAMET XR 150-1,000 MG TAB has ranged from a low of $6.8210 (Apr 19, 2017) to a high of $9.5802 (Jan 15, 2025), with a median of $8.7421 per EA.
Are there cheaper alternatives to INVOKAMET XR 150-1,000 MG TAB?
1 manufacturer publishes a NADAC-priced product with the same active ingredient and strength as INVOKAMET XR 150-1,000 MG TAB in a comparable dosage form, but none are currently priced below it.
Who manufactures INVOKAMET XR 150-1,000 MG TAB?
INVOKAMET XR 150-1,000 MG TAB (NDC 50458094301) is labeled by Janssen Pharmaceuticals Inc., and CMS classifies it as a brand product.